ABH Healthcare IPO Details: Key Dates, Price Band & Investment Overview

By Wealthova | Last Updated: August 21, 2026

ABH Healthcare Limited, a prominent healthcare provider operating the 150-bed Anil Baghi Hospital in Punjab, is gearing up to make its primary market debut with an upcoming ₹34.98 Crore SME IPO. Specializing in tertiary medical care across 25 clinical specialties—including cardiac sciences, neurology, and orthopaedics—the company operates a technology-enabled clinical infrastructure serving the Tier 3 catchment of Ferozepur and surrounding regions. The subscription window for this book-built issue opens on August 24 and closes on August 27, 2026. The price band is set between ₹96 to ₹102 per equity share, comprising entirely of a fresh issue of ₹34.98 Crore, with no Offer for Sale (OFS) component. The company plans to utilize the fresh capital primarily to fund strategic expansion—allocating funds for the repayment or prepayment of outstanding borrowings, meeting working capital requirements, and pursuing inorganic growth through unidentified acquisitions—alongside general corporate purposes. Set to list on the NSE SME platform, market participants are closely watching this established regional healthcare provider. Below, we break down the financial health, industry risk factors, and our honest Smart Market Insights to help you decide if you should subscribe to this issue!



ABH Healthcare IPO Details

Quick IPO Factsheet

Bidding Opens

August 24, 2026

Bidding Closes

August 26, 2026

Price Band

₹96 to ₹102

Lot Size

1,200 Shares

(Min. 2 Lots for Retail)
Total Issue Size

₹34.98 Cr

Fresh Issue Size

₹34.98 Cr

Retail Category

46.94% Allocation

Face Value

₹10 Base

Market Structure

SME (NSE Emerge)




ABH Healthcare IPO Timeline

IPO Open Date August 24, 2026
IPO Close Date August 26, 2026
Basis of Allotment August 27, 2026
Initiation of Refunds August 28, 2026
Credit to Demat Account August 28, 2026
NSE SME Listing Date August 31, 2026



Deep-Dive Corporate Profile: What Does ABH Healthcare Limited Do?

Incorporated in 2021, ABH Healthcare Limited operates the renowned Anil Baghi Hospital, a leading multi-specialty tertiary care facility located in Ferozepur, Punjab. Originally established in 1985 with just 30 beds, the hospital was acquired by the company in 2022 and has since transformed into a highly modernized, comprehensive healthcare hub.

Here is a breakdown of ABH Healthcare’s core operations and market presence:

  • Extensive Clinical Infrastructure: The hospital operates a 150-bed facility offering advanced medical treatment across 25 distinct clinical specialties. Core departments include cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, bariatric surgery, orthopaedics, and joint replacement.
  • Strong Insurance & TPA Network: To ensure accessible and cashless healthcare, the hospital is officially empanelled with over 30 private and public health insurance providers and third-party administrators (TPAs).
  • Government Scheme Integration: The hospital actively serves a massive patient base by participating in major government healthcare initiatives. They provide care to beneficiaries under the Ex-Servicemen Contributory Health Scheme (ECHS), Railways, Food Corporation of India (FCI), BSNL, and the Ayushman Bharat–Sarbat Sehat Bima Yojana.
  • Technology & Professional Care: ABH Healthcare relies on a doctor-led management team and focuses on maintaining a robust clinical infrastructure backed by modern medical equipment and digital IT systems for seamless patient experiences.


Why is the Company Raising Funds? (Objects of the Issue)

The ABH Healthcare IPO is a book-built SME issue comprising entirely of a Fresh Issue of ₹34.98 Crore (representing 34.29 Lakh shares). Importantly, there is no Offer for Sale (OFS) component, meaning 100% of the raised capital will go directly into the company.

The company intends to utilize the net proceeds from the fresh capital for the following strategic objectives:

  • Debt Repayment (₹17.00 Crore): A major portion of the funds will be deployed toward the prepayment or repayment of existing outstanding borrowings. This strategic deleveraging will significantly reduce the company's interest burden and boost post-IPO net profit margins.
  • Working Capital Requirements (₹5.00 Crore): ₹5.00 Crore will be allocated to fund ongoing working capital needs, ensuring smooth day-to-day hospital administration, inventory management, and operational efficiency.
  • Inorganic Growth & General Corporate Purposes: The remaining balance is earmarked to fund future inorganic growth through unidentified acquisitions (such as buying smaller regional clinics or diagnostic centers) and general corporate initiatives to strengthen their healthcare footprint.

📉 Debt Repayment 48.60%
💼 Working Capital 14.29%
🏛️ Acquisitions & GCP 37.11%



Company Financials

*All amounts are in ₹ Crores
📅 Period Ended 📈 Total Income 💼 Net Worth 💰 PAT 🏦 Assets
FY 2024 ₹41.39 ₹6.30 ₹1.66 ₹51.35
FY 2025 ₹49.32 ₹11.60 ₹5.35 ₹63.90
FY 2026 ₹52.59 ₹17.27 ₹5.64 ₹85.27



ABH Healthcare IPO Key Performance Indicators (KPIs)

Financial KPI (FY26)* Value
Return on Equity (ROE) 39.07% (FY26)
Return on Capital Employed (ROCE) 19.09% (FY26)
EBITDA Margin 28.03% (FY26)
PAT Margin 10.74% (FY26)
Debt to Equity Ratio 3.20 (FY26)
Return on Net Worth (RoNW) 39.07% (FY26)
Earnings Per Share (EPS) ₹7.05 (Pre-IPO) | ₹4.93 (Post-IPO)
Price/Earning (P/E) Ratio 14.47x (Pre-IPO) | 20.69x (Post-IPO)
Net Asset Value (NAV) ₹21.58 (Pre-IPO)



Promoters & Shareholding Pattern

Shareholder Category Pre-IPO Holding Post-IPO Holding
Promoter & Promoter Group 100.00% 69.99%
Public / Institutional / Others 0.00% 30.01%
💡
Smart Market Insights

ABH Healthcare Limited is promoted by Dr. Kamal Baghi, Saurabh Baghi, and Vaishali Saini. Prior to the issue, the promoter group held a complete 100.00% stake in the company. Post-issue, factoring in the ₹34.98 Crore fresh equity dilution (with absolutely no Offer for Sale), the promoter holding will adjust to 69.99%. The ₹17.00 Crore allocation directed toward debt repayment highlights the management's strategic focus on deleveraging the hospital's balance sheet, making their post-IPO valuation metrics highly competitive against other regional healthcare and hospital peers.

Industry Peer Comparison

Company Name EPS (₹) P/E Ratio (Post-IPO) RoNW (%)
ABH Healthcare Ltd (IPO) 4.93 20.69 39.07%
Kovai Medical Center & Hospital Ltd 97.45 38.50 18.15%
KMC Speciality Hospitals (India) Ltd 1.85 46.20 22.40%
Artemis Medicare Services Ltd 3.20 58.15 11.90%



IPO Strengths & Key Risks

Strengths
Established Regional Presence: ABH Healthcare operates the renowned 150-bed Anil Baghi Hospital, delivering comprehensive tertiary care across 25 clinical specialties, including cardiac sciences and neurology, in Ferozepur, Punjab.
Doctor-Led Professional Management: The company is driven by a highly experienced, doctor-led core management team with a proven track record of attracting and retaining renowned clinicians and specialized medical staff.
Diversified Payor Mix: To ensure accessible care and steady cash flows, the hospital is officially empanelled with over 30 private health insurance providers, TPAs, and major government schemes (ECHS, Railways, BSNL).
Robust Operating Infrastructure: Equipped with modern medical technology and IT systems, the hospital has demonstrated a stable financial trajectory, with total income scaling to ₹52.59 Crore and PAT reaching ₹5.64 Crore in FY26.
Key Risks
Single Facility Concentration: The company's entire revenue is generated from a single hospital located in Ferozepur. Any localized economic, regulatory, or demographic disruptions would severely and directly impact the business.
Elevated Debt Levels: The company carries a high Debt-to-Equity ratio of 3.20x as of FY26, which includes unsecured promoter loans and inter-corporate deposits from third parties that are repayable on demand.
Property Ownership Risk: ABH Healthcare does not own the land or premises where its registered office and hospital facility are located. Any lease dispute or forced eviction could severely disrupt critical hospital operations.
Limited Corporate Operating History: The company was specifically incorporated in 2021 to acquire the existing proprietorship of Anil Baghi Hospital. This limited corporate track record makes it difficult for investors to evaluate their future acquisition capabilities.
Healthcare Professional Dependency: The hospital relies heavily on its key promoters, senior doctors, and specialized staff. Furthermore, their arrangements with certain doctors may give rise to time-allocation constraints or conflicts of interest.



💡

Smart Market Insights

Wealthova Verdict: SUBSCRIBE (LONG TERM)

ABH Healthcare Limited occupies an established regional position in Punjab's healthcare ecosystem through its 150-bed multi-specialty tertiary care facility, Anil Baghi Hospital in Ferozepur. Providing specialized treatments across 25 clinical fields—including cardiac sciences, neurosurgery, and orthopaedics—the hospital benefits from strong patient loyalty, empanelment with over 30 insurance TPAs, and high participation in public welfare schemes (ECHS, Railways, Ayushman Bharat). This clinical foundation translated into total revenue of ₹52.59 Crore in FY26, alongside healthy operational profitability featuring an EBITDA margin of 28.03% and a PAT margin of 10.74%.

A major positive for incoming investors is the issue structure: the ₹34.98 Crore IPO is a 100% Fresh Issue with zero Offer for Sale (OFS), meaning no promoter is encashing equity. More importantly, allocating ₹17.00 Crore (48.60% of the proceeds) directly toward debt repayment strategically addresses the company's primary financial vulnerability—its elevated Debt-to-Equity ratio of 3.20x in FY26. Deleveraging will meaningfully lower finance costs and expand net profit margins post-listing. On the downside, investors must account for significant geographical concentration, as the company relies entirely on a single hospital operating on leased premises.

At the upper price band of ₹102, the stock is valued at a post-IPO P/E multiple of 20.69x (based on FY26 post-issue EPS of ₹4.93). This valuation leaves reasonable room on the table compared to listed hospital peers such as Kovai Medical (38.50x) and KMC Speciality (46.20x). Backed by an exceptional Return on Net Worth (RoNW) of 39.07% and substantial post-issue interest cost savings, ABH Healthcare is a fundamentally sound SME bet suitable for investors seeking regional healthcare exposure who are comfortable with single-facility concentration risks.

Disclaimer: The information provided above is for educational and informational purposes only and does not constitute financial advice. Initial Public Offerings (IPOs) carry market risks, and retail equities are subject to broader market fluctuations. Wealthova is not a SEBI-registered investment advisor. Always consult with a certified financial planner and conduct your own due diligence before locking up capital in any public issue.



ABH Healthcare IPO Key Contacts & Advisors

Role / Entity Contact & Details
📋 IPO Registrar Bigshare Services Private Limited

Office No S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri East, Mumbai – 400093, Maharashtra, India

🏢 Company Contact ABH Healthcare Limited (Anil Baghi Hospital)

Anil Baghi Road, Ferozepur – 152002, Punjab, India

💼 Merchant Bankers Fedex Securities Private Limited

B 7, 3rd Floor, Jay Chambers, Dayaldas Road, Vile Parle [East], Mumbai – 400057, Maharashtra, India

Website: fedsec.in



Frequently Asked Questions (FAQs)

What are the opening and closing dates for the ABH Healthcare IPO?
The ABH Healthcare IPO opens for subscription on August 24, 2026, and closes on August 26, 2026. The basis of allotment will be finalized on August 27, 2026, with the official stock market listing scheduled on the NSE SME platform for August 31, 2026.
What is the minimum lot size and investment required for retail investors?
While each market lot consists of 1,200 shares, retail investors are required to apply with a minimum of 2 lots (2,400 shares). At the upper price band of ₹102 per share, the minimum retail investment required is ₹2,44,800. High Net Worth Individuals (HNI) must apply for a minimum of 3 lots (3,600 shares), amounting to ₹3,67,200.
How can I check the allotment status for the ABH Healthcare IPO?
You can check your ABH Healthcare IPO allotment status online starting August 27, 2026, using any of the following methods:
  1. Wealthova (Recommended): Check directly on the Wealthova IPO Allotment Status Hub using your PAN number or Application Number for instant verification.
  2. Official Registrar Portal: Visit the official allotment portal of Bigshare Services Private Limited.
  3. Stock Exchange Portal: Verify directly on the official NSE IPO allotment status page.
Where will the ABH Healthcare IPO be listed?
ABH Healthcare Limited is an SME public issue, and its equity shares will be listed on the NSE SME (NSE Emerge) platform on August 31, 2026.
What is the total issue size and price band for the IPO?
The total issue size is ₹34.98 Crore, comprising a 100% Fresh Issue of ₹34.98 Crore (34.29 Lakh shares) with zero Offer for Sale (OFS). The book-built price band is set between ₹96 to ₹102 per equity share.
Who is the registrar and lead manager for this public issue?
Bigshare Services Private Limited is acting as the official IPO Registrar, while Fedex Securities Private Limited is the designated Book Running Lead Manager for the issue.